Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 6/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
| ▸ | RARA | P10276 | 1/20 | 0.32 |
| ▸ | RARB | P10826 | 1/20 | 0.32 |
| ▸ | RARG | P13631 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12440734 | 0.97 | PGR (0.40) | PGRPDK2HDAC1HDAC2HDAC3 | |
| SCHEMBL12744012 | 0.92 | PDK2 (0.38) | PGRPDK2MAPT | |
| SCHEMBL12744418 | 0.90 | PDK2 (0.37) | PGRPDK2MAPT | |
| SCHEMBL12744014 | 0.90 | PDK2 (0.37) | PGRPDK2MAPT | |
| SCHEMBL15070053 | 0.89 | PDK2 (0.39) | PGRPDK2 | |
| SCHEMBL14850147 | 0.88 | PGR (0.34) | PGRPDK2 | |
| SCHEMBL12619497 | 0.88 | PTGS1 (0.37) | PGRPDK2HDAC1HDAC2HDAC3 | |
| SCHEMBL15070055 | 0.88 | PDK2 (0.38) | PGRPDK2 | |
| SCHEMBL25681781 | 0.87 | PGR (0.34) | PGRPDK2 | |
| SCHEMBL13523423 | 0.86 | PDK2 (0.40) | PGRPDK2DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160013392-A1 | METHOD OF PRODUCING THERMOELECTRIC CONVERSION ELEMENT AND METHOD OF PREPARATION DISPERSION FOR THERMOELECTRIC CONVERSION LAYER | FUJIFILM CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-20140230871-A1 | THERMOELECTRIC CONVERSION MATERIAL AND THERMOELECTRIC CONVERSION ELEMENT | FUJIFILM CORPORATION (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20120232242-A1 | THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER | FUJI XEROX CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-8207348-B2 | Thiazolothiazole compound and thiazolothiazole polymer | FUJI XEROX CO., LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20110086999-A1 | THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER | FUJI XEROX CO., LTD. (JP) | 2011-04-14 | — | — | US | disclosed |
| US-20070120113-A1 | Supramolecular structures and method for forming the same | NATIONAL TAIWAN UNIVERSITY (TW) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086999-A1 | THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER | ARL1, IRAK1, TYK2 | PGR 1758/4885PDK2 690/4885HDAC1 173/4885 |
| US-20070120113-A1 | Supramolecular structures and method for forming the same | RDX, NBAS, SOD1 | PGR 1976/4885PDK2 4049/4885HDAC1 3939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.